Preliminary Evidence Suggests Feasibility of Early Immunotherapy Cessation in Metastatic Melanoma
Investigators reviewed the clinical outcomes of patients with metastatic melanoma who electively discontinued PD-1 inhibitor therapy at 1 year.
Christina Bennett, MS
Christina Bennett, MS, is an independent medical journalist who writes about a variety of medical topics, including oncology, health care policy, and cell and gene therapies. She has a bachelor's degree in biomedical science and a master’s degree in science and technology journalism, both from Texas A&M University. She is a member of the Association of Healthcare Journalists and the National Association of Science Writers and was one of a dozen journalists selected for the 2017 National Cancer Reporting Fellowships.
